Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery

Project Information

ULTRA-DD

Grant agreement ID: 115766

Project closed

Start date 1 March 2015

End date 29 February 2020

Funded under

• Specific Programme "Cooperation": Joint Technology Initiatives

Total cost

€ 50 308 785,00

EU contribution

€ 21 200 000,00

Coordinated by

NOVARTIS PHARMA AG
Switzerland